Necroptosis in immunity and ischemia-reperfusion injury

American Journal of Transplantation

Volumn 13, Issue 11, 2013, Pages 2797-2804

  Linkermann, A ^a   Hackl, M J ^b   Kunzendorf, U ^a   Walczak, H ^c   Krautwald, S ^a   Jevnikar, A M ^d,e  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e Matthew Mailing Center for Translational Transplant Studies   (Canada)

Author keywords

Apoptosis; necroptosis; necrostatin; regulated necrosis; RIPK1; RIPK3

Indexed keywords

CASPASE 8; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NECROSTATIN 1; PROTEIN KINASE; RECEPTOR INERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; APOPTOSIS; CELL STRUCTURE; CYTOSOL; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; NECROPTOSIS; NECROSTATIN; REGULATED NECROSIS; RIPK1; RIPK3;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; NECROSIS; REPERFUSION INJURY;

EID: 84886791222     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12448     Document Type: Review

References (72)

1. Oberst A, Green DR., It cuts both ways: Reconciling the dual roles of caspase 8 in cell death and survival. Nat Rev Mol Cell Biol 2011; 12: 757-763.
2. Tait SW, Green DR., Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-632.
3. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G., Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714.
4. Declercq W, Vanden Berghe T, Vandenabeele P., RIP kinases at the crossroads of cell death and survival. Cell 2009; 138: 229-232.
5. Han J, Zhong CQ, Zhang DW., Programmed necrosis: Backup to and competitor with apoptosis in the immune system. Nat Immunol 2011; 12: 1143-1149.
6. Kaczmarek A, Vandenabeele P, Krysko DV., Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209-223.
7. Kaiser WJ, Upton JW, Long AB, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011; 471: 368-372.
8. Oberst A, Dillon CP, Weinlich R, et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011; 471: 363-367.
9. Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112-119.
10. Degterev A, Hitomi J, Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4: 313-321.
11. Hitomi J, Christofferson DE, Ng A, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008; 135: 1311-1323.
12. Linkermann A, De ZF, Weinberg J, Kunzendorf U, Krautwald S., Programmed necrosis in acute kidney injury. Nephrol Dial Transplant 2012; 27: 3412-3419.
13. Linkermann A, Brasen JH, Himmerkus N, et al. Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012; 81: 751-761.
14. Ladoire S, Hannani D, Vetizou M, et al. Cell-death-associated molecular patterns as determinants of cancer immunogenicity. Antioxid Redox Signal 2013; [Epub ahead of print].
15. Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P., RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007; 14: 400-410.
16. Vanlangenakker N, Vanden Berghe T, Vandenabeele P., Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 2012; 19: 75-86.
17. Vercammen D, Beyaert R, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998; 187: 1477-1485.
18. Rieser E, Cordier SM, Walczak H., Linear ubiquitination: A newly discovered regulator of cell signalling. Trends Biochem Sci 2013; 38: 94-102.
19. Walczak H., TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol Rev 2011; 244: 9-28.
20. Gerlach B, Cordier SM, Schmukle AC, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011; 471: 591-596.
21. Haas TL, Emmerich CH, Gerlach B, et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 2009; 36: 831-844.
22. Ikeda F, Deribe YL, Skanland SS, et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 2011; 471: 637-641.
23. Tokunaga F, Nakagawa T, Nakahara M, et al. SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 2011; 471: 633-636.
24. Boisson B, Laplantine E, Prando C, et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol 2012; 13: 1178-1186.
25. Bertrand MJ, Milutinovic S, Dickson KM, et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008; 30: 689-700.
26. Vanlangenakker N, Vanden Berghe T, Bogaert P, et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 2011; 18: 656-665.
27. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM., An induced proximity model for caspase-8 activation. J Biol Chem 1998; 273: 2926-2930.
28. van Raam BJ, Ehrnhoefer DE, Hayden MR, Salvesen GS., Intrinsic cleavage of receptor-interacting protein kinase-1 by caspase-6. Cell Death Differ 2013; 20: 86-96.
29. O'Donnell MA, Perez-Jimenez E, Oberst A, et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011; 13: 1437-1442.
30. Peter ME., Programmed cell death: Apoptosis meets necrosis. Nature 2011; 471: 310-312.
31. Rusai K, Sollinger D, Baumann M, et al. Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 2010; 25: 853-860.
32. Ko GJ, Jang HR, Huang Y, et al. Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury. J Am Soc Nephrol 2011; 22: 732-742.
33. Mocarski ES, Upton JW, Kaiser WJ., Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 2011; 12: 79-88.
34. Moquin D, Chan FK., The molecular regulation of programmed necrotic cell injury. Trends Biochem Sci 2010; 35: 434-441.
35. Zhao J, Jitkaew S, Cai Z, et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA 2012; 109: 5322-5327.
36. Sun L, Wang H, Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148: 213-227.
37. Christofferson DE, Yuan J., Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 2010; 22: 263-268.
38. Wang Z, Jiang H, Chen S, Du F, Wang X., The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012; 148: 228-243.
39. Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332-336.
40. He S, Wang L, Miao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100-1111.
41. Cho YS, Challa S, Moquin D, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137: 1112-1123.
42. Newton K, Sun X, Dixit VM., Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 2004; 24: 1464-1469.
43. Upton JW, Kaiser WJ, Mocarski ES., Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 2008; 283: 16966-16970.
44. Upton JW, Kaiser WJ, Mocarski ES., Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010; 7: 302-313.
45. Linkermann A, Brasen JH, De Zen F, et al. Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor alpha-induced shock. Mol Med 2012; 18: 577-586.
46. Welz PS, Wullaert A, Vlantis K, et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011; 477: 330-334.
47. Gunther C, Martini E, Wittkopf N, et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 2011; 477: 335-339.
48. Lin J, Li H, Yang M, et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 2013; 3: 200-210.
49. Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE., Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 2013; 57: 1773-1783.
50. Liedtke C, Bangen JM, Freimuth J, et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 2011; 141: 2176-2187.
51. Trichonas G, Murakami Y, Thanos A, et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA 2010; 107: 21695-21670.
52. Murakami Y, Matsumoto H, Roh M, et al. Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci USA 2012; 109: 14598-14603.
53. Duprez L, Takahashi N, Van HF, et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 2011; 35: 908-918.
54. Cauwels A, Janssen B, Waeytens A, Cuvelier C, Brouckaert P., Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol 2003; 4: 387-393.
55. Takahashi N, Duprez L, Grootjans S, et al. Necrostatin-1 analogues: Critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 2012; 3: e437.
56. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA., Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32.
57. Martin SJ, Henry CM, Cullen SP., A perspective on mammalian caspases as positive and negative regulators of inflammation. Mol Cell 2012; 46: 387-397.
58. Kovalenko A, Kim JC, Kang TB, et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med 2009; 206: 2161-2177.
59. Luthi AU, Cullen SP, McNeela EA, et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009; 31: 84-98.
60. Bonnet MC, Preukschat D, Welz PS, et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 2011; 35: 572-582.
61. Chavez-Valdez R, Martin LJ, Flock DL, Northington FJ., Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia. Neuroscience 2012; 219: 192-203.
62. Li Y, Yang X, Ma C, Qiao J, Zhang C., Necroptosis contributes to the NMDA-induced excitotoxicity in rat's cultured cortical neurons. Neurosci Lett 2008; 447: 120-123.
63. Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ., Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011; 31: 178-189.
64. You Z, Savitz SI, Yang J, et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2008; 28: 1564-1573.
65. Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J., Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011; 471: 373-376.
66. Dillon CP, Oberst A, Weinlich R, et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012; 1: 401-407.
67. Biton S, Ashkenazi A., NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell 2011; 145: 92-103.
68. Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM., Necrostatin: A potentially novel cardioprotective agent ? Cardiovasc Drugs Ther 2007; 21: 227-233.
69. Liu J, van MA, Vrijsen K, et al. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med 2011; 15: 1474-1482.
70. Oerlemans MI, Liu J, Arslan F, et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol 2012; 107: 270.
71. Linkermann A, Braesen JH, Darding M, et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 2013; 110: 12024-12029.
72. Lau A, Wang S, Jiang J, et al. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant 2013; 13: 2805-2818.